Aggressive lipid lowering in postcoronary angioplasty patients with elevated cholesterol (the Lovastatin Restenosis Trial).

Journal Article

A substudy of the Lovastatin Restenosis Trial in patients with elevated cholesterol (>200 mg/dl) showed no evidence of an effect of aggressive lipid lowering on restenosis, confirming the results of the main trial.

Full Text

Duke Authors

Cited Authors

  • Boccuzzi, SJ; Weintraub, WS; Kosinski, AS; Roehm, JB; Klein, JL

Published Date

  • March 1, 1998

Published In

Volume / Issue

  • 81 / 5

Start / End Page

  • 632 - 636

PubMed ID

  • 9514463

International Standard Serial Number (ISSN)

  • 0002-9149

Language

  • eng

Conference Location

  • United States